OPTIMAL RANGE FOR LOW-DENSITY LIPOPROTEIN (LDL) FOR DIABETIC PATIENTS ON STATIN THERAPY FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS

• Huvudskapare: Riaz Mahmood, DO, MS (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Elsevier, 2024-09-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

Therapeutic Area: CVD Prevention - Primary and Secondary Background: Cholesterol-lowering medications such as HMG-CoA reductase inhibitors or statins are a guideline recommendation for the prevention of cardiovascular events in patients with diabetes over the age of 40. High-intensity statins can re...